P53 mutations in lymphomas: position matters.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

1. From regulation to deregulation of p53 in hematologic malignancies: implications for diagnosis, prognosis and therapy.Biomarker research · 2024
   Review
2. Small-molecule MMRi36 induces apoptosis in p53-mutant lymphomas by targeting MDM2/MDM4/XIAP for degradation.Frontiers in oncology · 2024
   Article
3. The clinicopathological and molecular features of sinusoidal large B-cell lymphoma.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2021
   Article
4. Lineage-negative lymphoma with a helper innate lymphoid cell phenotype.Virchows Archiv : an international journal of pathology · 2020
   Article
5. Rare cases of primary central nervous system anaplastic variant of diffuse large B-cell lymphoma.Diagnostic pathology · 2019
   Article
6. Transcriptional Regulation by Wild-Type and Cancer-Related Mutant Forms of p53.Cold Spring Harbor perspectives in medicine · 2017
   Review
7. The p53 Mutation/Deletion Profile in a Small Cohort of the Omani Population with Diffuse Large B-Cell Lymphoma.Sultan Qaboos University medical journal · 2014
   Article
8. A novel radiation-induced p53 mutation is not implicated in radiation resistance via a dominant-negative effect.PloS one · 2014
   Article
9. Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study.Blood · 2012
   Article
10. p53 Research: the past thirty years and the next thirty years.Cold Spring Harbor perspectives in biology · 2010
    Review
11. Mutations in TP53 are exclusively associated with del(17p) in multiple myeloma.Haematologica · 2010
    Article

Corrections and comments

• Comment on
  Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study.2008
• Comment on
  The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer overall survival.2008

Authors and funding

2 authors at 1 institution in 2 countries.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.